Post by messi05 on Jan 21, 2024 23:52:25 GMT -6
No repercussions, which would be considered a simple annoyance. For the rapporteur of the appeal, judge Antonio Mário de Castro Figliolia, the occurrence of moral damage and the appellant's responsibility remained proven. “Particular attention must be paid to the seriousness of the conduct, taking into account that the defendant was not only insulted in his dignity and integrity but also accused of committing a crime. Everything indelibly, that is, in writing, through information officially contained in the consumption invoice for the respective service,” he wrote.
Understanding that there is a risk to the life Buy Phone Number List of a man with stomach cancer, judge José Luiz Mônaco da Silva, of the São Paulo Court of Justice, immediately forced a health plan to pay for medicine not included in the list of the National Health Agency. Health Surveillance (Anvisa) for the next 90 days. In the decision, which reformed first-degree precautionary measures, the judge stipulated a daily fine of R$1,000 in case of non-compliance. “The health condition of the appellant is so serious that he is admitted to the ICU […] Therefore, given the legal requirements, notably the probability of the invoked right, I grant the effects of the appeal protection requested so that the defendant, within 5 days, pays the treatment prescribed with the medicine 'Keytruda'”, said the judge in the preliminary injunction.
The man took action against the plan after being diagnosed with stomach cancer in 2015. Due to the rapid development of the disease, the doctor treating him prescribed the drug Keytruda, which is not included in Anvisa's list, but has already is used in studies abroad. The health plan refused to pay for the treatment, claiming that approval from a medical board would be necessary. But this procedure is also not covered by the agreement. According to the plaintiff's lawyer, Simon Zveiter, the patient is unable to afford this type of collegiate consultation, because he has paid out of pocket for the medication, which costs R$20,000 per dose — which must be administered every three weeks.
Understanding that there is a risk to the life Buy Phone Number List of a man with stomach cancer, judge José Luiz Mônaco da Silva, of the São Paulo Court of Justice, immediately forced a health plan to pay for medicine not included in the list of the National Health Agency. Health Surveillance (Anvisa) for the next 90 days. In the decision, which reformed first-degree precautionary measures, the judge stipulated a daily fine of R$1,000 in case of non-compliance. “The health condition of the appellant is so serious that he is admitted to the ICU […] Therefore, given the legal requirements, notably the probability of the invoked right, I grant the effects of the appeal protection requested so that the defendant, within 5 days, pays the treatment prescribed with the medicine 'Keytruda'”, said the judge in the preliminary injunction.
The man took action against the plan after being diagnosed with stomach cancer in 2015. Due to the rapid development of the disease, the doctor treating him prescribed the drug Keytruda, which is not included in Anvisa's list, but has already is used in studies abroad. The health plan refused to pay for the treatment, claiming that approval from a medical board would be necessary. But this procedure is also not covered by the agreement. According to the plaintiff's lawyer, Simon Zveiter, the patient is unable to afford this type of collegiate consultation, because he has paid out of pocket for the medication, which costs R$20,000 per dose — which must be administered every three weeks.